Cancer Research AACR Conference on Molecular Diagnostics - 2008  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 37, 2092-2098, July 1, 1977]
© 1977 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Waite, M.
Right arrow Articles by Morris, H. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Waite, M.
Right arrow Articles by Morris, H. P.

The Deacylation and Reacylation of Phosphoglyceride in Microsomes of Morris Hepatoma 7777 and Host Rat Liver1

Moseley Waite2, Bruce Parce, Richard Morton, Carol Cunningham and Harold P. Morris

Department of Biochemistry, The Bowman Gray School of Medicine, Winston-Salem, North Carolina 27103 [M. W., B. P., R. M., C. C.], and Biochemical Cancer Research Unit, Howard University, Washington, D. C. 20001 [H. P. M.]

We describe here a decrease in the ratio of phospholipids to protein in microsomes prepared from Morris hepatoma 7777, compared with those from host rat liver. These microsomes, characterized by their marker enzyme content, were found to have comparable enrichment of the NADPH cytochrome c reductase. In addition to the decrease in phospholipid content, the major phospholipids had decreased polyunsaturated and increased monounsaturated fatty acids. Analysis of the free fatty acid pool of the two indicates a marked decrease in linoleic acid in this hepatoma microsome; very little longer-chain polyunsaturated fatty acid was found. The major difference in the ratio of the phospholipids was an increase in the hepatoma microsome sphingomyelin content. The hepatoma 7777 microsomes incorporated oleoyl-coenzyme A into monoacylphospholipids more rapidly than did the liver. When free fatty acids were used with an acyl-coenzyme A-generating system, the liver microsomes were more active than those from hepatoma. Furthermore, frozen and thawed microsomes from the hepatoma 7777 had little capacity to use free fatty acids, whereas liver microsomes were unaffected by freezing and thawing. These results indicate that the fatty acid-activating enzyme of hepatoma microsomes is more labile than that of liver. Both samples had phospholipase(s) that were active on the microsomal membrane phospholipids. No accumulation of monoacylphosphoglyceride was found in the hepatoma, whereas about one-half of the diacylphospholipid degraded by liver microsomes remained as the monoacylphosphoglyceride. This indicates that the precursor for reacylation in the Lands' cycle (deacylation-reacylation) is decreased in the hepatoma. We conclude from these results that, in part, the changes found in the activities of the Lands' cycle system account for the alterations in hepatoma phospholipid composition, both quantitatively and qualitatively.

1 Supported by USPHS Grants CA 14318 and CA 10729, and by the Forsyth Cancer Service.

2 Recipient of NIH Career Development Award AM 17392.

Received 1/14/77. Accepted 4/11/77.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1977 by the American Association for Cancer Research.